Jaishri Blakeley

Jaishri Blakeley

UNVERIFIED PROFILE

Are you Jaishri Blakeley?   Register this Author

Register author
Jaishri Blakeley

Jaishri Blakeley

Publications by authors named "Jaishri Blakeley"

Are you Jaishri Blakeley?   Register this Author

100Publications

2299Reads

41Profile Views

Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.

Skeletal Radiol 2020 Feb 8;49(2):199-219. Epub 2019 Aug 8.

The Russell H. Morgan Department of Radiology & Radiological Science, The Johns Hopkins University School of Medicine, 601 North Caroline Street, JHOC 3rd Floor, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-019-03290-1DOI Listing
February 2020

The Diagnosis and Management of Neurofibromatosis Type 1.

Med Clin North Am 2019 Nov;103(6):1035-1054

Department of Neurology and Neurosurgery, Johns Hopkins University, 600 North Wolfe Street, Meyer 100, Baltimore, MD 21287, USA; Department of Oncology, Johns Hopkins University, 600 North Wolfe Street, Meyer 100, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcna.2019.07.004DOI Listing
November 2019

Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

Neurology 2019 09 8;93(11):e1076-e1084. Epub 2019 Aug 8.

From The Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000008092DOI Listing
September 2019

Association between patient-reported outcomes and objective disease indices in people with NF2.

Neurol Clin Pract 2019 Aug;9(4):322-329

Johns Hopkins School of Medicine (AS, BS, SL, JOB), the Johns Hopkins Comprehensive Neurofibromatosis Center, Baltimore, MD; Department of Biostatistics and Data Science (F-CH), Wake Forest School of Medicine, Winston-Salem, NC; Division of Biostatistics and Epidemiology (YL), Weill Cornell Medical College, New York; Department of Neurology (RES), Wake Forest School of Medicine, Winston-Salem, NC; and Department of Neurology (RES), Johns Hopkins School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745746PMC
August 2019

Effect of ketogenic diets on leukocyte counts in patients with epilepsy.

Nutr Neurosci 2019 Jul 18;22(7):522-527. Epub 2017 Dec 18.

f Department of Neurology , Carnegie 214B, 1800 Orleans Street, Baltimore , MD 21287 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1028415X.2017.1416740DOI Listing
July 2019

An update on the central nervous system manifestations of neurofibromatosis type 1.

Acta Neuropathol 2019 Apr 8. Epub 2019 Apr 8.

Department of Pathology, Johns Hopkins University School of Medicine, Sheikh Zayed Tower, Room M2101, 1800 Orleans Street, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00401-019-02002-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819239PMC
April 2019

Creating a comprehensive research strategy for cutaneous neurofibromas.

Neurology 2018 07;91(2 Suppl 1):S1-S4

From the Department of Neurology (J.O.B., R.J., M.S., S.K.V.), The Johns Hopkins School of Medicine, The Neurofibromatosis Therapeutic Acceleration Program, Baltimore, MD; Department of Dermatology (P.W.), Paris Est Créteil University, France; Pediatric Oncology Branch (B.C.W.), National Cancer Institute, NIH, Bethesda, MD; Dermavant Sciences (J.L.), Durham, NC; and Department of Dermatology (L.Q.L.), UT Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000005789DOI Listing
July 2018

Cutaneous neurofibromas: Current clinical and pathologic issues.

Neurology 2018 07;91(2 Suppl 1):S5-S13

From the Departments of Pathology (N.O.) and Dermatology (P.W.), French Referral Center for Neurofibromatoses, Henri-Mondor Hospital, AP-HP, University Paris Est Créteil, France; Department of Neurology (J.O.B., S.K.V.), Johns Hopkins University School of Medicine, The Neurofibromatosis Therapuetic Acceleration Program, Baltimore, MD; University of Alabama at Birmingham (B.K.); Cancer Center and Department of Neurology (S.R.P.) and Department of Pathology, Division of Neuropathology (A.S.-R.), Massachusetts General Hospital, Boston; The Neurofibromatosis Institute (V.M.R.), La Crescenta, CA; Department of Pathology & Anatomical Sciences (D.C.M.), University of Missouri School of Medicine, Columbia; Manchester Centre for Genomic Medicine (S.H.), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK; Institute of Biomedicine (J.P.), University of Turku, Finland; Department of Pathology and Laboratory Medicine (A.R.), Jackson Memorial Hospital/University of Miami Miller School of Medicine, FL; Department of Pathology and Laboratory Medicine (S.L.C.), Medical University of South Carolina, Charleston; Clinics and Polyclinics of Neurology (V.M.), University Hospital Hamburg-Eppendorf, Hamburg, Germany; and Division of Cancer and Genetics (M.U.), Institute of Medical Genetics, Cardiff University, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005792DOI Listing
July 2018

The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities.

Neurology 2018 07;91(2 Suppl 1):S14-S20

From the Department of Dermatology (J.P.B., L.Q.L.), UT Southwestern Medical Center, Dallas, TX; Dermatology Branch (D.C.P., I.B.), Center for Cancer Research, National Cancer Institutes of Health, Bethesda, MD; Human Genetics Department (E.H.L.), University of Leuven, Belgium; Division Cancer Immunity Transplantation Infections (P.W.), Paris Est Créteil University, France; Department of Dermatology (R.M.L.), Northwestern University, Chicago, IL; Department of Neurology (J.O.B., S.K.V.), The Neurofibromatosis Therapeutic Acceleration Program, The Johns Hopkins University School of Medicine, Baltimore, MD; and The NF Institute (V.M.R.), La Crescenta, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005788DOI Listing
July 2018

Considerations for development of therapies for cutaneous neurofibroma.

Neurology 2018 07;91(2 Suppl 1):S21-S30

From the Department of Neurology (S.K.V., J.O.B.), The Johns Hopkins University School of Medicine, The Neurofibromatosis Therapeutic Acceleration Program, Baltimore, MD; The NF Institute (V.M.R.), La Crescenta, CA; Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston; Division of Plastic Surgery (H.W.), Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Dermatology (R.R.A.), Harvard Medical School, Boston, MA; BioPharm Tech (K.J.), San Mateo, CA; and Dermavant Sciences (J.L.), Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005791DOI Listing
July 2018

Clinical trial design for cutaneous neurofibromas.

Neurology 2018 07;91(2 Suppl 1):S31-S37

From the Department of Genetics (A.C., B.K.), University of Alabama at Birmingham; BioPharm Tech (K.J.), San Mateo, CA; Pediatric Oncology Branch (B.C.W.) and Dermatology Branch, Center for Cancer Research (D.C.P.), National Cancer Institute, NIH, Bethesda; Division of Oncology Products (D.C.) and Division of Dermatology and Dental Products (H.-S.K.), Food and Drug Administration, Silver Spring; and Department of Neurology (J.O.B., S.K.V.), The Neurofibromatosis Therapeutic Acceleration Program, The Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005790DOI Listing
July 2018

Voice and Swallowing Dysfunction in Neurofibromatosis 2.

Otolaryngol Head Neck Surg 2018 03 21;158(3):505-510. Epub 2017 Nov 21.

2 Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599817741839DOI Listing
March 2018

Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative.

Lancet Oncol 2018 03;19(3):e173-e180

Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30004-4DOI Listing
March 2018

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.

Am J Hum Genet 2018 01 28;102(1):69-87. Epub 2017 Dec 28.

Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2017.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777934PMC
January 2018

Common Histologically Benign Tumors of the Brain.

Continuum (Minneap Minn) 2017 12;23(6, Neuro-oncology):1680-1708

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CON.0000000000000541DOI Listing
December 2017

Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.

Eur J Cancer 2017 09 10;83:9-18. Epub 2017 Jul 10.

Department of Radiology, Johns Hopkins University, Baltimore, MD, USA; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572540PMC
September 2017

Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.

Neurotherapeutics 2017 04;14(2):298-306

Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13311-017-0518-y
Publisher Site
http://dx.doi.org/10.1007/s13311-017-0518-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398990PMC
April 2017

Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.

World Neurosurg 2017 Mar 19;99:19-25. Epub 2016 Nov 19.

Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2016.11.051DOI Listing
March 2017

Low-grade Schwann cell neoplasms with leptomeningeal dissemination: clinicopathologic and autopsy findings.

Hum Pathol 2017 02 22;60:121-128. Epub 2016 Sep 22.

Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.08.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285484PMC
February 2017

Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas.

Acta Neuropathol 2016 11 20;132(5):761-763. Epub 2016 Sep 20.

Department of Pathology, Johns Hopkins University, Sheikh Zayed Tower, Room M2101, 1800 Orleans Street, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00401-016-1619-0DOI Listing
November 2016

Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.

J Magn Reson Imaging 2016 10 17;44(4):794-803. Epub 2016 Mar 17.

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.25236DOI Listing
October 2016

Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1.

Neurology 2016 Aug;87(7 Suppl 1):S13-20

From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston; Section of Pediatric Pulmonology, Allergy and Sleep Medicine (S.D.D.), and Stem Cell Transplantation Program (K.A.R.), Riley Children's Hospital, Indiana University School of Medicine, Indianapolis; Pediatric Oncology Branch (S.A., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Pulmonary Medicine (J.A.), Division of Oncology (M.J.F.), and Sleep Center (C.L.M.), Children's Hospital of Philadelphia; Department of Pediatrics (M.J.F.) and Sleep Center (C.L.M.), The Perelman School of Medicine at the University of Pennsylvania (J.A.), Philadelphia; Department of Neurology (J.O.B.), John Hopkins Medical Institute, Baltimore, MD; and Department of Neurology (R.E.F.), Guy's and St. Thomas' NHS Foundation Trust and Institute of Psychiatry, King's College London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578358PMC
August 2016

Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Neurology 2016 Aug;87(7 Suppl 1):S31-9

From The Russell H. Morgan Department of Radiology and Radiological Science (S.A., L.M.F., M.A.J.), Sidney Kimmel Comprehensive Cancer Center (M.A.J.), and Department of Neurology (J.O.B.), Johns Hopkins University, Baltimore, MD; Khyber Medical College (M.S.K.), Peshawar, Pakistan; Department of Radiology (M.A.B., G.J.H., W.C.), Massachusetts General Hospital and Harvard Medical School, Boston; Genomic Medicine (D.G.E.), Manchester Academic Health Science Centre, The University of Manchester, UK; Department of Neurology (S.F., V.F.M.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Radiology & Orthopedic Surgery (A.C.), UT Southwestern Medical Center, Dallas, TX; Department of Diagnostic and Interventional Radiology (J.M.S.), University Hospital Hamburg-Eppendorf; Radiological Practice Altona (R.W.), Hamburg, Germany; Pediatric Oncology Branch (E.D.), National Cancer Institute, Bethesda, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578359PMC
August 2016

Current status and recommendations for biomarkers and biobanking in neurofibromatosis.

Neurology 2016 Aug;87(7 Suppl 1):S40-8

From Plymouth University (C.O.H.), Peninsula Schools of Medicine and Dentistry, The Institute of Translational and Stratified Medicine, Plymouth, UK; Department of Neurology (J.O.B.), Johns Hopkins University Medical School, Baltimore, MD; Department of Pediatrics (F.P.N.) and Department of Pediatrics, School of Medicine (K.R., M.F.), Indiana University; Tailored Therapeutics (F.P.N.), Eli Lilly and Company, Indianapolis, IN; Department of Pathology (A.S.-R.), Neuro-oncology (S.R.P.), Massachusetts General Hospital, Boston; Neurologische Klinik (V.M.), Uniklinik Eppendorf, Hamburg; Berlin-Brandenburg Center for Regenerative Therapies (A.K.), Charité Universitätsmedizin Berlin, Germany; Seoul National University (A.K.), College of Veterinary Medicine and Research Institute for Veterinary Science, Republic of Korea; NCI (B.C.W.), Pediatric Oncology Branch, Bethesda, MD; Genomic Medicine (D.G.E.), University of Manchester, UK; National Neurofibromatosis Service (R.F.), Department of Neurology, Guy's and St. Thomas' NHS Foundation Trust, London UK; Department of Pathology and Laboratory Medicine (S.L.C.), Medical University of South Carolina, Charleston; and Heflin Center for Genomic Sciences (B.K.), University of Alabama at Birmingham; Dermatology (P.W.), GHU Henri Mondor, Paris, France; Children's Tumor Foundation (P.K.), New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578360PMC
August 2016

Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.

PLoS One 2015 14;10(12):e0144620. Epub 2015 Dec 14.

Department of Neurology, The Johns Hopkins School of Medicine, Baltimore, MD, 21205, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144620PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682832PMC
June 2016

Cutaneous manifestations in neuro-oncology: clinically relevant tumor and treatment associated dermatologic findings.

Semin Oncol 2016 06 23;43(3):401-7. Epub 2016 Feb 23.

Department of Neurology, Wake Forest School of Medicine, Winston Salem, NC; Department of Neurology and Oncology, Johns Hopkins School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.02.029DOI Listing
June 2016

Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Neuro Oncol 2016 05 6;18(5):624-38. Epub 2016 Feb 6.

Neurology, Neurosurgery and Oncology, Johns Hopkins University, Baltimore, MD (J.O.B.); Neurology, Harvard Medical School, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA (S.R.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827037PMC
May 2016

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

J Clin Oncol 2016 05 14;34(14):1669-75. Epub 2016 Mar 14.

Jaishri O. Blakeley, Xiaobu Ye, Amanda L. Bergner, Laura M. Fayad, Shivani Ahlawat, and Michael A. Jacobs, Johns Hopkins University, Baltimore; Christopher Zalewski, National Institute on Deafness and Other Communication Disorders; Eva Dombi and Brigitte C. Widemann, National Cancer Institute, Bethesda, MD; Dan G. Duda, Alona Muzikansky, Vanessa L. Merker, Elizabeth R. Gerstner, Rakesh K. Jain, and Scott R. Plotkin, Massachusetts General Hospital; and Chris F. Halpin, Massachusetts Eye and Ear Infirmary, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.3817DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872317PMC
May 2016

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.

Neuro Oncol 2016 Mar;18 Suppl 2:ii13-ii20

Johns Hopkins University, Departments of Neurology, Neurosurgery and Oncology, Baltimore, Maryland (J.O.B.); Critical Path Institute, 1730 E. River Road, Tucson, Arizona (S.J.C.); University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, 12631 East 17th Avenue B185, Aurora, Colorado (J.R.C.); Evidera, 7101 Wisconsin Avenue, Suite 1400, Bethesda, Maryland (N.K.L.); University of Texas MD Anderson Cancer Center, 1515 Holcombe Bld., Houston, Texas (T.R.M., J.S.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795998PMC
March 2016

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD).

Neuro Oncol 2016 Mar;18 Suppl 2:ii26-ii36

National Brain Tumor Society, Newton, Massachusetts (J.L.H.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W.); Department of Neuro-Oncology, Johns Hopkins University, Brain Cancer Program, Baltimore, Maryland (J.B.); Center for Cancer Research, Neuro-Oncology Branch, National Cancer Institute, Bethesda, Maryland (M.R.G.); The University of Texas Health Science Center at Houston, School of Nursing, Department of Family Health, Houston, Texas (T.S.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795997PMC
March 2016

Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients.

Tomography 2015 Dec;1(2):105-114

Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18383/j.tom.2015.00175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710854PMC
December 2015

Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.

Neurooncol Pract 2015 Sep 26;2(3):127-136. Epub 2015 May 26.

Department of Neurology , Johns Hopkins School of Medicine , Baltimore, Maryland (R.E.S., M.C.C., E.H.K., A.L.H., J.O.B.); Department of Pediatrics , Johns Hopkins School of Medicine , Baltimore, Maryland (E.H.K., A.L.H.); Department of Oncology , Johns Hopkins School of Medcine , Baltimore, Maryland (J.O.B.); Institute for Clinical and Translational Research , Johns Hopkins School of Medicine , Baltimore, Maryland (B.J.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671322PMC
September 2015

Clinical Management of Seizures in Patients With Low-Grade Glioma.

Semin Radiat Oncol 2015 Jul 23;25(3):219-24. Epub 2015 Feb 23.

Department of Neurology, Neurosurgery, and Oncology, The Johns Hopkins University, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2015.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696025PMC
July 2015

How critical is the blood-brain barrier to the development of neurotherapeutics?

JAMA Neurol 2015 Apr;72(4):381-2

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland3Departments of Neurology and Neurosurgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Mar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.3736DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778419PMC
April 2015

18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.

J Nucl Med 2015 Mar 5;56(3):379-85. Epub 2015 Feb 5.

Division of Nuclear Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.114.142372DOI Listing
March 2015

Clinical response to bevacizumab in schwannomatosis.

Neurology 2014 Nov 22;83(21):1986-7. Epub 2014 Oct 22.

From The Johns Hopkins Hospital (J.O.B., K.C.S., A.L.B., A.J.B.), Baltimore, MD; St. Mary's Hospital (D.G.E.), Manchester, UK; University of Alabama at Birmingham (B.K.); and NYU Langone Medical Center (D.Z., M.A.K.), New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000997DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248457PMC
November 2014

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma.

Neurology 2014 Jul 13;83(3):235-9. Epub 2014 Jun 13.

From the Brain Cancer Program (M.H., P.A., A.A., G.S., J.B., S.A.G., X.Y.), The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and Departments of Oncology (M.H., S.A.G.), Radiology (D.B.), Neurology (J.B.), and Neurosurgery (X.Y.), The Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://www.neurology.org/content/83/3/235.full.pdf
Web Search
http://www.neurology.org/cgi/doi/10.1212/WNL.000000000000059
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000000593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117362PMC
July 2014

Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis.

ISRN Radiol 2013 7;2013:627932. Epub 2013 Oct 7.

The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA ; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5402/2013/627932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045550PMC
June 2014

Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models.

J Neurooncol 2014 Jan 2;116(1):59-65. Epub 2013 Nov 2.

Department of Neurosurgery, Johns Hopkins University School of Medicine, CRB II, Suite 2M45, 1550 Orleans Street, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1268-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037922PMC
January 2014

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Neuro Oncol 2014 Jan 26;16(1):113-22. Epub 2013 Nov 26.

Corresponding authors: Kaisorn L. Chaichana, MD, The Johns Hopkins Hospital, Department of Neurosurgery, Johns Hopkins University, 600 North Wolfe Street, Meyer 8-184, Baltimore, MD 21202. Alfredo Quiñones-Hinojosa, MD, The Johns Hopkins Hospital, Department of Neurosurgery, Johns Hopkins University, Cancer Research Building II, 1550 Orleans Street, Room 247, Baltimore, MD 21231

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870832PMC
January 2014

Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.

J Magn Reson Imaging 2013 Nov 25;38(5):1119-28. Epub 2013 Feb 25.

Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jmri.24067
Publisher Site
http://dx.doi.org/10.1002/jmri.24067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664658PMC
November 2013

Achieving consensus for clinical trials: the REiNS International Collaboration.

Neurology 2013 Nov;81(21 Suppl 1):S1-5

From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The Jennifer and Daniel Gilbert Neurofibromatosis Institute (K.S.W.), Children's National Medical Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000435743.49414.b6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908338PMC
November 2013

Hearing and facial function outcomes for neurofibromatosis 2 clinical trials.

Neurology 2013 Nov;81(21 Suppl 1):S25-32

From the Neurology Department and Cancer Center (S.R.P.) and Neurosurgical Service (F.G.B.), Massachusetts General Hospital, Boston, MA; Department of Neurology and Neurosurgery (S.L.A.-H.), The Children's Hospital at Westmead, University of Sydney, Australia; Department of Neurology and Oncology (J.O.B.), John Hopkins Medical Institute, Baltimore, MD; University Department of Medical Genetics (D.G.E.), St Mary's Hospital, Manchester, UK; Department of Neurology (R.E.F.), Guy's and St. Thomas' NHS Foundation Trust and Institute of Psychiatry, King's College London, UK; Department of Otolaryngology (T.A.H.) and Audiology (C.H.), Massachusetts Eye and Ear Infirmary; and Harvard Medical School (T.A.H.), Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000435746.02780.f6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908336PMC
November 2013

Conclusions and future directions for the REiNS International Collaboration.

Neurology 2013 Nov;81(21 Suppl 1):S41-4

From the Pediatric Oncology Branch (B.C.W., E.D., P.L.W.), National Cancer Institute, Bethesda, MD; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; The Jennifer and Daniel Gilbert Neurofibromatosis Institute (K.S.W.), Children's National Medical Center, Washington, DC; and Neurology Department and Cancer Center (S.R.P.). Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://www.neurology.org/content/81/21_supplement_1/S41.full
Web Search
http://www.neurology.org/cgi/doi/10.1212/01.wnl.0000435748.7
Publisher Site
http://dx.doi.org/10.1212/01.wnl.0000435748.79908.c5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908339PMC
November 2013

Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.

Skeletal Radiol 2013 Sep 7;42(9):1317-22. Epub 2013 May 7.

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 North Wolfe Street, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-013-1626-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991125PMC
September 2013

Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma.

J Neurooncol 2013 Sep 5;114(3):275-9. Epub 2013 Jul 5.

Ludwig Center for Cancer Genetics and Therapeutics, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1182-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133769PMC
September 2013

Plexiform nerve sheath tumor or vascular malformation--role of advanced MR neurography and diffusion tensor imaging.

Skeletal Radiol 2013 Jul 22;42(7):1007-10. Epub 2013 Mar 22.

Russell H Morgan Department of Radiology & Radiological Science, 601 N. Caroline St, JHOC 3262, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00256-013-1594-7
Publisher Site
http://dx.doi.org/10.1007/s00256-013-1594-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991119PMC
July 2013

Histopathological correlates with survival in reoperated glioblastomas.

J Neurooncol 2013 Jul 11;113(3):485-93. Epub 2013 May 11.

Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1141-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994532PMC
July 2013

Multiple resections for patients with glioblastoma: prolonging survival.

J Neurosurg 2013 Apr 19;118(4):812-20. Epub 2012 Oct 19.

Department of Neurosurgery, Johns Hopkins University, Baltimore, MD 21202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2012.9.JNS1277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700339PMC
April 2013

Optimizing biologically targeted clinical trials for neurofibromatosis.

Expert Opin Investig Drugs 2013 Apr 21;22(4):443-62. Epub 2013 Feb 21.

Washington University School of Medicine, Department of Neurology and Washington University Neurofibromatosis Center, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.2013.77
Publisher Site
http://dx.doi.org/10.1517/13543784.2013.772979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009992PMC
April 2013

Clinical reasoning: Multiple cranial neuropathies in a young man.

Neurology 2013 Feb;80(6):e60-6

Department of Neurology, Johns Hopkins University, Baltimore, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e3182815441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589290PMC
February 2013

Increased risk of breast cancer in women with NF1.

Am J Med Genet A 2012 Dec 19;158A(12):3056-60. Epub 2012 Nov 19.

Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.35550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507419PMC
December 2012

Use of personalized molecular biomarkers in the clinical care of adults with glioblastomas.

J Neurooncol 2012 Nov 29;110(2):279-85. Epub 2012 Aug 29.

Brain Cancer Program, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0968-3DOI Listing
November 2012

Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma.

Authors:
Jaishri Blakeley

Curr Opin Otolaryngol Head Neck Surg 2012 Oct;20(5):372-9

Johns Hopkins University, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOO.0b013e328357d2eeDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778430PMC
October 2012

The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas.

Cancer Chemother Pharmacol 2012 Jul 27;70(1):129-39. Epub 2012 May 27.

Department of Neurosurgery, Tel-Aviv Medical Center, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-012-1867-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005329PMC
July 2012

Chemotherapy with cytotoxic and cytostatic agents in brain cancer.

Handb Clin Neurol 2012 ;104:229-54

John Hopkins Hospital, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-52138-5.00017-7DOI Listing
April 2012

Tissue concentration of systemically administered antineoplastic agents in human brain tumors.

J Neurooncol 2011 Sep 12;104(3):629-38. Epub 2011 Mar 12.

University of Manitoba, 675 McDermot Avenue, Winnipeg, MB, R3E 0V9, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-011-0564-y
Publisher Site
http://dx.doi.org/10.1007/s11060-011-0564-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020433PMC
September 2011

Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development.

Expert Opin Drug Metab Toxicol 2010 Dec 23;6(12):1477-91. Epub 2010 Oct 23.

Johns Hopkins University, Neurosurgery and Oncology, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2010.523420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994531PMC
December 2010